A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer
2010 ◽
Vol 28
(15_suppl)
◽
pp. TPS295-TPS295
2014 ◽
Vol 32
(15_suppl)
◽
pp. e19039-e19039
◽
2011 ◽
Vol 17
(6)
◽
pp. 1553-1560
◽
2017 ◽
Vol 49
(4)
◽
pp. 1001-1011
◽